Search

Search Results

• The incidence of infection, diagnosis and treatment of H. pylori in developing countries on the example of Kenya

  Dominik Machaj, Sandra Jastrzębska, Katarzyna Cyboran, Alicja Płaczek, Wiktoria Flaumenhaft

  11-17

  2020-03-04
• Expanding the knowledge of Helicobacter pylori – new directions, new challenges

  Jakub Wronecki, Ewa Tywanek, Paulina Trojanowska, Barbara Skrzydło-Radomańska, Agnieszka Zwolak, Robert Jan Łuczyk

  770-776

  2020-09-26
• Features of the distribution of the concentration on the mucous stomach of active and inactive forms of helicobacterial infection in patients with chronic non-atrophic gastritis, suffering and not suffering from chronic constipation

  I. N. Shukhtina, A. A. Avramenko

  1254-1264

  2019-09-30
• Helicobacter pylori cytotoxin-associated gene A virulence and its association with the epithelial-mesenchymal transition in gastric cancer

  Iga Dudek, Alicja Forma, Justyna Hamerska, Michał Flieger, Jacek Januszewski, Tomasz Cywka, Joanna Kozak, Jacek Baj

  62-75

  2022-04-08
• The influence of Helicobacter pylori on the level of endotheline-1 and nitrogen oxide in the blood of children with the duodenal ulcer

  Tаmila Sorokman, Nadiia Chernei, Snizhana Sokolnyk, Iryna Sokolnyk, Nataliya Popelyuk

  261-272

  2020-11-30
• Helicobacter pylori and its effect on the body. Worldwide prevalence of Helicobacter pylori

  I. Shukhtina, V. Shukhtin, A. Gozhenko, A. Avramenko, N. Badiuk

  734-740

  2016-06-29
• Helicobacter pylori infection and arteriosclerosis

  Tamara Anna Rakszewska, Adam Alzubedi

  503-506

  2019-04-26
• Оцінка лікування виразки дванадцятипалої кишки у дітей з точки зору відновлення репаративної функції = The estimation of treatment in children with duodenal ulcer from the perspective of reparative function recovery

  V. M. Dudnyk, N. O. Buglova

  579-588

  2016-07-31
• Морфологічні особливості виразки дванадцятипалої кишки у дітей в залежності від тяжкості захворювання та наявності Н. Pylori інфекції = Morphological features of duodenal ulcer in children, depending on the severity of the disease and the presence of H. Pylori infection

  V. M. Dudnyk, N. O. Buglova

  253-262

  2016-06-11
• Влияние температурного режима на уреазную активность хеликобактерной инфекции = Effects of temperature on urease activity of h. Pylori infection

  A. A. Avramenko, I. N. Shuhtina, V. V. Shuhtin, L. M. Bobrik, R. N. Boris, W. Zukow

  318-322

  2015-10-31
• Гепатопротекторные свойства квертулина при экспериментальной антихеликобактерной терапии = Kvertulin hepatoprotective properties in experimental therapy of H. Pylori

  Irina N Shuhtina

  47-54

  2015-03-19
• Helicobacter pylori treatment - a review

  Kamil Hurkała, Dominika Antonik, Barbara Denys, Karolina Góra, Wojciech Zdziennicki, Patryk Zimnicki, Marta Lato, Konrad Iberszer, Maria Litwiniuk, Marcin Zaniuk

  23-32

  2023-06-13
• The frequency of detection of the active form of helicobacter pylori infection in patients with chronic non-atrophic gastritis with biliary dyskinesia on the hypotonic hypokinetic type and with preserved function of the gall bladder

  R. N. Korolenko, A. A. Avramenko

  471-479

  2019-02-28
• Risk factors of the gastric cancer – the short review

  Piotr Michał Jarosz, Paweł Oszczędłowski, Michalina Pytka, Justyna Nowaczek

  783-792

  2020-09-27
• Risk factors for gallbladder cancer

  Magdalena Suchodolska, Blanka Świerczyńska, Adrian Undziakiewicz, Krzysztof Smoluchowski, Michał Sekuła

  487-493

  2020-09-22
• Features of Helicobacter pylori virulence. Literature review

  A. Avramenko, I. Shukhtina, A. Gozhenko, V. Shukhtin, N. Badiuk

  1344-1352

  2019-09-30
• DEVELOPMENT OF DYSBIOSIS AND INFLAMMATION IN RATS TREATED WITH ANTI-HELICOBACTER PYROLI THERAPY AND PREVENTION USING ANTIDYSBIOTIC DRUG "QUERTULIDON"

  I. N. Shuhtina, A. A. Petrenko, O. E. Uspensky, A. I. Gozhenko, V. V. Shuhtin, L. M. Bobrik, R. N. Boris

  227-237

  2015-11-17
• Clinical studies of phytogel "Kvertulidon" stomatoprotective action in patients with helicobacter gastritis

  O. E. Uspensky, P. I. Pustovoit

  423-428

  2019-07-26
• Gastric lymphoma - epidemiology, clinical manifestations and current therapy management

  Adrian Hunek, Magdalena Alicja Zapała, Karolina Chmielarz, Karolina Kaziród, Joanna Wiśniewska-Skomra, Kinga Tylutka, Anna Hapon, Mikołaj Dadziak

  283-296

  2023-08-29
• Marker profile of digestive system organs comorbid pathology in children

  Snizhana Vasylivna Sokolnyk, Tamila Vasylivna Sorokman, Ganna Borysivna Bodnar, Pavlo Mykhailovych Moldovan, Iryna Yaroslavivna Loziuk, Nadiia Yaroslavivna Vaskul

  272-278

  2020-10-30
• Развитие дисбиоза и воспаления в организме крыс, получавших антихеликобактерную терапию и их профилактика антидисбиотическим препаратом «квертулидон» = Development of dysbiosis and inflammation in rats treated with anti-helicobacter pyroli therapy and prevention using antidysbiotic drug "quertulidon"

  I. N. Shuhtina, A. A. Petrenko, O. E. Uspensky, A. I. Gozhenko

  619-628

  2016-07-01
• Pathogenesis of abdominal aortic aneurysms from the vascular surgeon perspective – knowledge summary

  Willy Hauzer, Jan Gnus , Paula Hauzer, Joanna Rosińczuk

  62-67

  2022-12-12
• A case of worsening condition of armed forces of ukraine fighter after treatment for chronic non-atrophic gastritis excernsation

  A. Avramenko, A. Magdenko, V. Dymo

  55490

  2024-09-24
• The relevance of probiotics in therapy

  Konrad Grzeszczak, Aleksandra Strońska, Karolina Rogulska

  80-85

  2021-08-14
• The effect of mucosal-adhesive phytogels “Kvertulin” and “Lekvin” on the state of the oral cavity in patients with helicobacter pylori-associated pathology of gastroduodenal area by the data of dental indices

  S. I. Bogatu

  165-184

  2019-01-22
• Childhood obesity - risk factors and prevention strategies

  Barbara Magiera, Jakub Rybak, Karol Magiera, Piotr Bator, Michał Razik, Patrycja Rozwadowska, Jan Ramian, Wiktor Razik

  175-187

  2024-02-16
• Особенности течения хронического неатрофического гастрита у водителей дальних рейсов = Features of chronic non-atrophic gastritis in long-haul drivers

  Anatoliy A. Avramenko, Rimma N. Korolenko, Sergey N. Smolyakov

  79-86

  2015-02-21
• Vonoprazan - a new drug for inhibiting gastric acid secretion

  Kacper Niewęgłowski, Natalia Wilczek, Michał Rycharski, Julita Niewęgłowska

  661-670

  2022-08-24
• Peculiarities of pathogenesis of gastric cancer formed in the treatment of chronic non-atrophic gastritis by proton pump inhibitors

  A. A. Avramenko, S. N. Smolyakov

  546-556

  2018-11-30
• Central Serous Chorioretinopathy or a stressful lifestyle predisposes to the disease? - review of the current literature

  Ewelina Dybała, Izabela Dybała-Przygrodzka, Iwona Cuber, Magdalena Mazurek, Edyta Białowąs, Artur Aghadi

  252-261

  2023-02-09
• Education and health behavior of patients with gastric ulcer

  Agnieszka Zastawna, Bożena Baczewska, Robert Jan Łuczyk, Alina Dzirba

  191-199

  2017-11-17